FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079131854> ?p ?o ?g. }

• W2079131854 endingPage "1095" @default.
• W2079131854 startingPage "1090" @default.
• W2079131854 abstract "Patients who undergo orthotopic liver transplantation (OLT) for Budd-Chiari syndrome (BCS) traditionally have been anticoagulated with warfarin postoperatively. Because a significant proportion of BCS patients are found to have an underlying myeloproliferative disorder (MPD), antiplatelet therapy may be a more rational treatment strategy for this subgroup.All patients who underwent OLT for the diagnosis of BCS at our institution through March 2000 were included in this analysis. Posttransplant therapy consisted of hydroxyurea and aspirin for those with MPDs. Standard anticoagulation or no antithrombotic treatment was given to BCS patients with other causes. Major posttransplantation complications (thrombosis and bleeding) and mortality were determined.Seventeen patients underwent OLT for BCS at our institution. The mean follow-up was 68.4 months. Two of seventeen patients died; one patient died of recurrent thrombosis (124 months after OLT) and the other patient died of acute hepatitis B (7 months after OLT). Twelve patients (71%) had evidence of a MPD. Two of the MPD patients were treated with warfarin before the initiation of hydroxyurea and aspirin therapy. The remaining 10 MPD patients were placed on only hydroxyurea and aspirin after OLT. Anagrelide was used in place of hydroxyurea in two patients because of cytopenias caused by the latter agent. The mean follow-up of this group of 10 patients was 59.9 months. Only one patient experienced recurrent thrombosis, which occurred more than 10 years after the original transplant. There were no major bleeding complications and posttransplant liver biopsies were well tolerated.Antiplatelet therapy that consists of hydroxyurea and aspirin is a safe and effective alternative to anticoagulation to prevent recurrent thrombosis in MPD patients with BCS after liver transplantation. For patients with a hypercoagulable state corrected by OLT, antithrombotic therapy probably is not required. For those patients with conditions not corrected by OLT or with idiopathic BCS, anticoagulation or other therapy to control the hypercoagulable state should be given." @default.
• W2079131854 created "2016-06-24" @default.
• W2079131854 creator A5028562673 @default.
• W2079131854 creator A5035594574 @default.
• W2079131854 creator A5041266112 @default.
• W2079131854 creator A5063705635 @default.
• W2079131854 creator A5064618296 @default.
• W2079131854 creator A5073266707 @default.
• W2079131854 creator A5078861466 @default.
• W2079131854 creator A5081597750 @default.
• W2079131854 date "2002-10-01" @default.
• W2079131854 modified "2023-10-06" @default.
• W2079131854 title "Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders1" @default.
• W2079131854 cites W1660798880 @default.
• W2079131854 cites W1861925901 @default.
• W2079131854 cites W1876989967 @default.
• W2079131854 cites W1983122197 @default.
• W2079131854 cites W1994558526 @default.
• W2079131854 cites W2011874753 @default.
• W2079131854 cites W2016339584 @default.
• W2079131854 cites W2018050721 @default.
• W2079131854 cites W2019850350 @default.
• W2079131854 cites W2020880151 @default.
• W2079131854 cites W2021033641 @default.
• W2079131854 cites W2033732447 @default.
• W2079131854 cites W2035150821 @default.
• W2079131854 cites W2069387007 @default.
• W2079131854 cites W2079377322 @default.
• W2079131854 cites W2084490803 @default.
• W2079131854 cites W2088936920 @default.
• W2079131854 cites W2136791825 @default.
• W2079131854 cites W2139824837 @default.
• W2079131854 cites W2316177409 @default.
• W2079131854 cites W2394822652 @default.
• W2079131854 cites W4239691152 @default.
• W2079131854 doi "https://doi.org/10.1097/00007890-200210270-00006" @default.
• W2079131854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12438952" @default.
• W2079131854 hasPublicationYear "2002" @default.
• W2079131854 type Work @default.
• W2079131854 sameAs 2079131854 @default.
• W2079131854 citedByCount "82" @default.
• W2079131854 countsByYear W20791318542012 @default.
• W2079131854 countsByYear W20791318542013 @default.
• W2079131854 countsByYear W20791318542014 @default.
• W2079131854 countsByYear W20791318542015 @default.
• W2079131854 countsByYear W20791318542016 @default.
• W2079131854 countsByYear W20791318542017 @default.
• W2079131854 countsByYear W20791318542018 @default.
• W2079131854 countsByYear W20791318542019 @default.
• W2079131854 countsByYear W20791318542020 @default.
• W2079131854 countsByYear W20791318542021 @default.
• W2079131854 countsByYear W20791318542022 @default.
• W2079131854 crossrefType "journal-article" @default.
• W2079131854 hasAuthorship W2079131854A5028562673 @default.
• W2079131854 hasAuthorship W2079131854A5035594574 @default.
• W2079131854 hasAuthorship W2079131854A5041266112 @default.
• W2079131854 hasAuthorship W2079131854A5063705635 @default.
• W2079131854 hasAuthorship W2079131854A5064618296 @default.
• W2079131854 hasAuthorship W2079131854A5073266707 @default.
• W2079131854 hasAuthorship W2079131854A5078861466 @default.
• W2079131854 hasAuthorship W2079131854A5081597750 @default.
• W2079131854 hasConcept C126322002 @default.
• W2079131854 hasConcept C141071460 @default.
• W2079131854 hasConcept C2776208725 @default.
• W2079131854 hasConcept C2776301958 @default.
• W2079131854 hasConcept C2777015399 @default.
• W2079131854 hasConcept C2777628954 @default.
• W2079131854 hasConcept C2779161974 @default.
• W2079131854 hasConcept C2779609443 @default.
• W2079131854 hasConcept C2780868729 @default.
• W2079131854 hasConcept C2910216633 @default.
• W2079131854 hasConcept C2911091166 @default.
• W2079131854 hasConcept C71924100 @default.
• W2079131854 hasConcept C90924648 @default.
• W2079131854 hasConceptScore W2079131854C126322002 @default.
• W2079131854 hasConceptScore W2079131854C141071460 @default.
• W2079131854 hasConceptScore W2079131854C2776208725 @default.
• W2079131854 hasConceptScore W2079131854C2776301958 @default.
• W2079131854 hasConceptScore W2079131854C2777015399 @default.
• W2079131854 hasConceptScore W2079131854C2777628954 @default.
• W2079131854 hasConceptScore W2079131854C2779161974 @default.
• W2079131854 hasConceptScore W2079131854C2779609443 @default.
• W2079131854 hasConceptScore W2079131854C2780868729 @default.
• W2079131854 hasConceptScore W2079131854C2910216633 @default.
• W2079131854 hasConceptScore W2079131854C2911091166 @default.
• W2079131854 hasConceptScore W2079131854C71924100 @default.
• W2079131854 hasConceptScore W2079131854C90924648 @default.
• W2079131854 hasIssue "8" @default.
• W2079131854 hasLocation W20791318541 @default.
• W2079131854 hasLocation W20791318542 @default.
• W2079131854 hasOpenAccess W2079131854 @default.
• W2079131854 hasPrimaryLocation W20791318541 @default.
• W2079131854 hasRelatedWork W1791055574 @default.
• W2079131854 hasRelatedWork W2091438702 @default.
• W2079131854 hasRelatedWork W2114891295 @default.
• W2079131854 hasRelatedWork W2129460911 @default.
• W2079131854 hasRelatedWork W2350951690 @default.
• W2079131854 hasRelatedWork W2387870739 @default.

• next